JP2923181B2 - 高濃度のカルシウムを含有する水溶性粉末およびその製造方法 - Google Patents
高濃度のカルシウムを含有する水溶性粉末およびその製造方法Info
- Publication number
- JP2923181B2 JP2923181B2 JP5232951A JP23295193A JP2923181B2 JP 2923181 B2 JP2923181 B2 JP 2923181B2 JP 5232951 A JP5232951 A JP 5232951A JP 23295193 A JP23295193 A JP 23295193A JP 2923181 B2 JP2923181 B2 JP 2923181B2
- Authority
- JP
- Japan
- Prior art keywords
- calcium
- water
- organic acid
- powder
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000011575 calcium Substances 0.000 title claims description 97
- 229910052791 calcium Inorganic materials 0.000 title claims description 97
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title claims description 96
- 239000004552 water soluble powder Substances 0.000 title claims description 8
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 150000007524 organic acids Chemical class 0.000 claims description 34
- 239000000843 powder Substances 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 13
- 239000007921 spray Substances 0.000 claims description 11
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 claims description 10
- 239000000292 calcium oxide Substances 0.000 claims description 10
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims description 10
- 241000237502 Ostreidae Species 0.000 claims description 7
- 235000020636 oyster Nutrition 0.000 claims description 7
- 241001474374 Blennius Species 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 235000013997 pineapple juice Nutrition 0.000 claims description 5
- 235000007119 Ananas comosus Nutrition 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 3
- 241000234671 Ananas Species 0.000 claims 1
- 238000002360 preparation method Methods 0.000 description 19
- 235000013336 milk Nutrition 0.000 description 18
- 239000008267 milk Substances 0.000 description 18
- 210000004080 milk Anatomy 0.000 description 18
- 239000000243 solution Substances 0.000 description 11
- 235000019640 taste Nutrition 0.000 description 11
- 235000013305 food Nutrition 0.000 description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- 210000000988 bone and bone Anatomy 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 229930003316 Vitamin D Natural products 0.000 description 6
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229940093915 gynecological organic acid Drugs 0.000 description 6
- 235000005985 organic acids Nutrition 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 235000019166 vitamin D Nutrition 0.000 description 6
- 239000011710 vitamin D Substances 0.000 description 6
- 150000003710 vitamin D derivatives Chemical class 0.000 description 6
- 229940046008 vitamin d Drugs 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- 239000011230 binding agent Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 206010006956 Calcium deficiency Diseases 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- 244000099147 Ananas comosus Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 102000003982 Parathyroid hormone Human genes 0.000 description 2
- 108090000445 Parathyroid hormone Proteins 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 239000000199 parathyroid hormone Substances 0.000 description 2
- 229960001319 parathyroid hormone Drugs 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 241000242757 Anthozoa Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000037147 Hypercalcaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102220547770 Inducible T-cell costimulator_A23L_mutation Human genes 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 240000009164 Petroselinum crispum Species 0.000 description 1
- YUGCAAVRZWBXEQ-UHFFFAOYSA-N Precholecalciferol Natural products C=1CCC2(C)C(C(C)CCCC(C)C)CCC2C=1C=CC1=C(C)CCC(O)C1 YUGCAAVRZWBXEQ-UHFFFAOYSA-N 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 241001261506 Undaria pinnatifida Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 150000001669 calcium Chemical class 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- UFLSLGGVXPPUDQ-UHFFFAOYSA-N dicalcium oxygen(2-) Chemical compound [O--].[O--].[Ca++].[Ca++] UFLSLGGVXPPUDQ-UHFFFAOYSA-N 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000000148 hypercalcaemia Effects 0.000 description 1
- 208000030915 hypercalcemia disease Diseases 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000005368 osteomalacia Diseases 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5232951A JP2923181B2 (ja) | 1993-09-20 | 1993-09-20 | 高濃度のカルシウムを含有する水溶性粉末およびその製造方法 |
| TW082108469A TW283631B (ref) | 1993-09-20 | 1993-10-13 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5232951A JP2923181B2 (ja) | 1993-09-20 | 1993-09-20 | 高濃度のカルシウムを含有する水溶性粉末およびその製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0789852A JPH0789852A (ja) | 1995-04-04 |
| JP2923181B2 true JP2923181B2 (ja) | 1999-07-26 |
Family
ID=16947422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5232951A Expired - Fee Related JP2923181B2 (ja) | 1993-09-20 | 1993-09-20 | 高濃度のカルシウムを含有する水溶性粉末およびその製造方法 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP2923181B2 (ref) |
| TW (1) | TW283631B (ref) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI227670B (en) * | 1997-05-21 | 2005-02-11 | Fujix Inc | A process for the preparation of a calcium antagonist |
| US6863910B2 (en) | 2001-10-16 | 2005-03-08 | Maruo Calcium Company Limited | Inorganic particles-containing additive composition, manufacturing method thereof and food composition containing the additive composition |
| JP2004049212A (ja) * | 2002-05-27 | 2004-02-19 | Ics Kk | 易吸収性ミネラル含有健康食品並びに其の製造方法 |
| MX2010011378A (es) | 2008-04-16 | 2010-11-12 | Procter & Gamble | Composicion no espumante para el cuidado personal en forma de un articulo. |
| JP5146762B2 (ja) * | 2008-10-22 | 2013-02-20 | 有限会社エス・エヌ・イー総合研究所 | 天然ミネラルイオン含有土壌改良剤 |
| MX2011006130A (es) | 2008-12-08 | 2011-07-20 | Procter & Gamble | Sustratos solidos, solubles y porosos, y complejos de perfume de ciclodextrina alojados en la superficie. |
| JPWO2010110477A1 (ja) * | 2009-03-27 | 2012-10-04 | 直 岩附 | アスベスト溶解剤およびアスベスト無害化湿式処理方法 |
| WO2011071964A1 (en) | 2009-12-08 | 2011-06-16 | The Procter & Gamble Company | A porous, dissolvable solid substrate and a surface resident coating of cationic surfactant conditioner |
| MX2012006249A (es) | 2009-12-08 | 2012-06-19 | Procter & Gamble | Un sustrato solido soluble poroso y un material acondicionador de surfactante cationico. |
| JP5956925B2 (ja) | 2010-03-31 | 2016-07-27 | 東洋水産株式会社 | カルシウム剤およびその製造方法 |
| US20180163325A1 (en) | 2016-12-09 | 2018-06-14 | Robert Wayne Glenn, Jr. | Dissolvable fibrous web structure article comprising active agents |
| MX345025B (es) | 2010-07-02 | 2017-01-12 | Procter & Gamble | Producto detergente. |
| RU2541949C2 (ru) | 2010-07-02 | 2015-02-20 | Дзе Проктер Энд Гэмбл Компани | Филаменты, содержащие активный агент, нетканые полотна и способы их получения |
| MX382405B (es) | 2010-07-02 | 2025-03-13 | Procter & Gamble | Método para suministrar un agente activo. |
| WO2012166478A2 (en) | 2011-05-27 | 2012-12-06 | The Procter & Gamble Company | Soluble solid hair coloring article |
| CN103582474A (zh) | 2011-05-27 | 2014-02-12 | 宝洁公司 | 可溶性固体毛发着色制品 |
| JP6362226B2 (ja) | 2014-04-22 | 2018-07-25 | ザ プロクター アンド ギャンブル カンパニー | 溶解性固体構造物の形態の組成物 |
| EP4245296B1 (en) | 2017-01-27 | 2024-07-17 | The Procter & Gamble Company | Compositions in the form of dissolvable solid structures |
| MX380727B (es) | 2017-01-27 | 2025-03-12 | Procter & Gamble | Composiciones en la forma de estructuras sólidas solubles que comprenden partículas aglomeradas efervescentes. |
| CN110650723A (zh) | 2017-05-16 | 2020-01-03 | 宝洁公司 | 可溶性固体结构形式的调理毛发护理组合物 |
| EP3520798A1 (en) * | 2018-01-31 | 2019-08-07 | Omya International AG | Use of functionalized calcium carbonate as active ingredient |
| JP1629688S (ref) | 2018-07-16 | 2019-04-15 | ||
| US11666514B2 (en) | 2018-09-21 | 2023-06-06 | The Procter & Gamble Company | Fibrous structures containing polymer matrix particles with perfume ingredients |
| EP3989913A1 (en) | 2019-06-28 | 2022-05-04 | The Procter & Gamble Company | Dissolvable solid fibrous articles containing anionic surfactants |
| JP7393441B2 (ja) | 2019-07-03 | 2023-12-06 | ザ プロクター アンド ギャンブル カンパニー | カチオン性界面活性剤及び可溶性酸を含有する繊維構造体 |
| USD939359S1 (en) | 2019-10-01 | 2021-12-28 | The Procter And Gamble Plaza | Packaging for a single dose personal care product |
| WO2021077133A1 (en) | 2019-10-14 | 2021-04-22 | The Procter & Gamble Company | Biodegradable and/or home compostable sachet containing a solid article |
| CA3157576A1 (en) | 2019-11-20 | 2021-05-27 | The Procter & Gamble Company | Porous dissolvable solid structure |
| US11896693B2 (en) | 2019-12-01 | 2024-02-13 | The Procter & Gamble Company | Hair conditioner compositions with a preservative system containing sodium benzoate and glycols and/or glyceryl esters |
| USD962050S1 (en) | 2020-03-20 | 2022-08-30 | The Procter And Gamble Company | Primary package for a solid, single dose beauty care composition |
| USD941051S1 (en) | 2020-03-20 | 2022-01-18 | The Procter And Gamble Company | Shower hanger |
| CN111481953A (zh) * | 2020-04-20 | 2020-08-04 | 广东一方制药有限公司 | 含淀粉中药喷干粉的生产方法 |
| USD965440S1 (en) | 2020-06-29 | 2022-10-04 | The Procter And Gamble Company | Package |
| EP4188554A1 (en) | 2020-07-31 | 2023-06-07 | The Procter & Gamble Company | Water-soluble fibrous pouch containing prills for hair care |
| WO2022036352A1 (en) | 2020-08-11 | 2022-02-17 | The Procter & Gamble Company | Clean rinse hair conditioner compositions containing brassicyl valinate esylate |
| CN116456957A (zh) | 2020-08-11 | 2023-07-18 | 宝洁公司 | 含有芸苔油醇缬氨酸酯乙磺酸盐的低粘度毛发调理剂组合物 |
| MX2023001045A (es) | 2020-08-11 | 2023-02-16 | Procter & Gamble | Composiciones acondicionadoras humectantes para el cabello que contienen esilato de valinato de brassicilo. |
| MX2023002189A (es) | 2020-09-10 | 2023-03-03 | Procter & Gamble | Articulo solido disoluble que contiene activos antibacterianos. |
| CA3201309A1 (en) | 2020-12-01 | 2022-06-09 | The Procter & Gamble Company | Aqueous hair conditioner compositions containing solubilized anti-dandruff actives |
| USD1045064S1 (en) | 2020-12-17 | 2024-10-01 | The Procter & Gamble Company | Single-dose dissolvable personal care unit |
| WO2022159368A1 (en) | 2021-01-21 | 2022-07-28 | The Procter & Gamble Company | Dissolvable solid article containing preservatives |
| JP2024529019A (ja) | 2021-08-20 | 2024-08-01 | ザ プロクター アンド ギャンブル カンパニー | シリコーンを含有する溶解性固体物品 |
| WO2023034763A1 (en) | 2021-08-30 | 2023-03-09 | The Procter & Gamble Company | Dissolvable solid structure comprising first and second polymeric structurants |
-
1993
- 1993-09-20 JP JP5232951A patent/JP2923181B2/ja not_active Expired - Fee Related
- 1993-10-13 TW TW082108469A patent/TW283631B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0789852A (ja) | 1995-04-04 |
| TW283631B (ref) | 1996-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2923181B2 (ja) | 高濃度のカルシウムを含有する水溶性粉末およびその製造方法 | |
| CN104222999B (zh) | 一种新型低钠盐的组成、制备和用途 | |
| CN103432161B (zh) | 多种维生素矿物质泡腾片及其制备方法 | |
| JPH06507640A (ja) | 混合カルシウム及びビタミンｄ補給品 | |
| RU2363269C2 (ru) | Аморфные водорастворимые соли цитрата кальция и способ их получения и применения | |
| WO1993020718A1 (fr) | Composition alimentaire inhibant la formation de produits de putrefaction intestinale | |
| WO2008014674A1 (fr) | Sel de potassium comestible nutritionnel et de soin ayant un large champ d'application | |
| TW201635920A (zh) | 肌肉合成促進劑 | |
| CN103462947B (zh) | 葡萄糖酸钙锌颗粒剂及其制法 | |
| CN1238008C (zh) | 一种促进人体排铅的药品或功能性食品及其制备方法 | |
| JPH07222571A (ja) | 運動選手用飲食品 | |
| US20040191296A1 (en) | Food additive | |
| JP7090849B2 (ja) | 肝機能改善用組成物及び肝機能改善用食品組成物 | |
| KR102126131B1 (ko) | 곤약 음료의 제조방법 | |
| CN1118296C (zh) | 一种苦瓜含片及其制备方法 | |
| CN106880054A (zh) | 一种预防和治疗肌肉萎缩症的保健食品及其制备方法 | |
| JPH04262762A (ja) | 食品用組成物、過食防止用食品および食品用組成物の製造方法 | |
| CN101176698A (zh) | 一种消除口腔苦味的产品及方法 | |
| KR20080090101A (ko) | 해조식품 매생이를 이용한 건강기능성 식품 및 그의제조방법 | |
| JP2564648B2 (ja) | 高濃度のイオン化カルシウムを含有する液状の食品添加剤およびその製造方法、ならびに該食品添加剤を添加した加工食品 | |
| CN110236062A (zh) | 一种桂花阿胶固体饮料及其制备方法 | |
| JP3655732B2 (ja) | 植物胚芽エキスを含有する食品 | |
| KR20060083282A (ko) | 섭취가 가능한 고농축 칼슘수용액 제조방법 및 이를이용한 칼슘이온음료 | |
| JPH10127254A (ja) | 便秘用健康食品 | |
| JP4001676B2 (ja) | 副甲状腺ホルモンの分泌抑制作用を有するカルシウム 拮抗剤・およびその製造方法ならびにその用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 19990420 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080430 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090430 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100430 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100430 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110430 Year of fee payment: 12 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120430 Year of fee payment: 13 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120430 Year of fee payment: 13 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130430 Year of fee payment: 14 |
|
| LAPS | Cancellation because of no payment of annual fees |